Abstract
Valproate is effective in treating bipolar disorder characterized by rapid cycling or acute mania, although the mechanism of action is unclear. In contrast to other treatments for depression, 21 days of treatment in rats with valproate (100, 200 or 400 mg/kg) did not significantly alter the hypothermia induced by 8-hydroxy-2-(di-n-propyl)aminotetralin (8-OH-DPAT), an agonist at serotonin-1A receptors. Treatment with valproate also had no effect on radioligand binding to serotonin-1A, serotonin-2 or β-adrenergic receptors. Based on these animal studies in frontal cortex and hippocampus, the therapeutic benefit of valproate in mood disorders does not appear to involve adaptive changes in serotonin-1A, serotonin-2 or β-adrenergic receptor number.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Biggs CS, Pearce BR, Fowler LJ, Whitton PS (1992) Regional effects of sodium valproate on extracellular concentrations of 5-hydroxytryptamine, dopamine and their metabolites in the rat brain: an in vivo microdialysis study. J Neurochem 59:1702–1708
Blier P, Bouchard C (1992) Effect of repeated electroconvulsive shocks on serotonergic neurons. Eur J Pharmacol 211:365–373
Blier P, de Montigney C, Chaput Y (1990) A role for the serotonin system in the mechanism of action of antidepressant treatments: preclinical evidence. J Clin Psychiatry 51[4, suppl]: 14–20
Calabrese JR, Markovitz PJ, Kimmel SE, Wagner SC (1992) Spectrum of efficacy of valproate in 78 rapid cycling bipolar patients. J Clin Psychopharmacol 12:53S-56S
Caldecott-Hazard S, Morgan DG, DeLeon-Jones F, Overstreet DH, Janowsky D (1991) Clinical and biochemical aspects of depressive disorders: II. transmitter/receptor theories. Synapse 9:251–301
Emrich HM, Wolf R (1992) Valproate treatment of mania. Prog Neuropsychopharmacol Biol Psychiatry 16:691–701
Goodwin GM, DeSouza RJ, Wood AJ, Green AR (1986) Lithium decreases 5-HT1A and 5-HT2 receptor and α2-adrenoceptor mediated function in mice. Psychopharmacology 90:482–487
Goodwin GM, DeSouza RJ, Green AR (1987) Attenuation by electroconvulsive shock and antidepressant drugs of the 5-HT1A receptor-mediated hypothermia and serotonin syndrome produced by 8-OH-DPAT in the rat. Psychopharmacology 91:500–505
Gudelsky GA, Koenig JI, Jackman H, Meltzer HY (1986a) Suppression of the hypo-and hyperthermic responses to 5-HT agonists following the repeated administration of monoamine oxidase inhibitors. Psychopharmacology 90:403–407
Gudelsky GA, Koenig J, Meltzer HY (1986b) Thermoregulatory responses to serotonin (5-HT) receptor stimulation in the rat. Evidence for opposing roles of 5-HT2 and 5-HT1A receptors. Neuropharmacology 25:1307–1313
Hutson PH, Sarna GS, O'Connell MT, Curzon G (1989) Hippocampal 5-HT synthesis and release in vivo is decreased by infusion of 8-OH-DPAT into the nucleus raphe dorsalis. Neurosci Lett 100:276–280
Lesch KP, Mayer S, Disselkamp-Tietze J, Hoh A, Schoellnhammer G, Schulte HM (1990) Subsensitivity of the 5-hydroxytryptamine1A (5-HT1A) receptor-mediated hypothermic response to ipsapirone in unipolar depression. Life Sci 46: 1271–1277
Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193:265–275
Motohashi N (1992) GABA receptor alterations after chronic lithium administration. Comparison with carbamazepine and sodium valproate. Prog Neuropsychopharmacol Biol Psychiatry 16:571–579
Odagaki Y, Koyama T, Matsubara S, Matsubara R, Yamashita I (1990) Effects of chronic lithium treatment on serotonin binding sites in rat brain. J Psychiatr Res 24:271–277
Pandey SC, Isaac L, Davis JM, Pandey GN (1991) Similar effects of treatment with desipramine and electroconvulsive shock on 5-hydroxytryptamine1A receptors in rat brain. Eur J Pharmacol 202:221–225
Peroutka SJ (1986) Pharmacological differentiation and characterization of 5-HT1A, 5-HT1B, and 5-HT1C binding sites in rat frontal cortex. J Neurochem 47:529–540
Pope HG, McElroy SL, Keck PE, Hudson JI (1991) Valproate in the treatment of acute mania. Arch Gen Psychiatry 48: 62–68
Sharp T, Bramwell SR, Lambert P, Grahame-Smith DG (1991) Effect of short- and long-term administration of lithium on the release of endogenous 5-HT in the hippocampus of the rat in vivo and in vitro. Neuropharmacology 30:977–984
Shukla GS (1985) Combined lithium and valproate treatment and subsequent withdrawal: serotonergic mechanism of their interaction in discrete brain regions. Prog Neuropsychopharmacol Biol Psychiatry 9:153–156
Siever LJ, Kahn RS, Lawlor BA, Trestman RL, Lawrence TL, Coccaro EF (1991) II. Critical issues in defining the role of serotonin in psychiatric disorders. Pharmacol Rev 43:509–525
Stockmeier CA, Wingenfeld P, Gudelsky GA (1992) Effects of repeated electroconvulsive shock on serotonin-1A receptor binding and receptor-mediated hypothermia in rat. Neuropharmacology 31:1089–1094
Treiser SL, Cascio CS, O'Donohue TL, Thoa NB, Jacobowitz DM, Kellar KJ (1981) Lithium increases serotonin release and decreases serotonin receptors in the hippocampus. Science 213:1529–1531
Wajda IJ, Banay-Schwartz M, Manigault I, Lajtha A (1986) Modulation of the serotonin S2-receptor in brain after chronic lithium. Neurochem Res 11:949–957
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Khaitan, L., Calabrese, J.R. & Stockmeier, C.A. Effects of chronic treatment with valproate on serotonin-1A receptor binding and function. Psychopharmacology 113, 539–542 (1994). https://doi.org/10.1007/BF02245236
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF02245236